16-2027059-G-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The ENST00000424542.7(NHERF2):c.54G>T(p.Glu18Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000012 in 1,413,436 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000424542.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NHERF2 | NM_001130012.3 | c.54G>T | p.Glu18Asp | missense_variant | 1/7 | ENST00000424542.7 | NP_001123484.1 | |
NHERF2 | NM_004785.6 | c.54G>T | p.Glu18Asp | missense_variant | 1/7 | NP_004776.3 | ||
NHERF2 | XM_047434923.1 | c.54G>T | p.Glu18Asp | missense_variant | 1/7 | XP_047290879.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NHERF2 | ENST00000424542.7 | c.54G>T | p.Glu18Asp | missense_variant | 1/7 | 1 | NM_001130012.3 | ENSP00000408005 | P1 | |
NHERF2 | ENST00000432365.6 | c.54G>T | p.Glu18Asp | missense_variant | 1/7 | 1 | ENSP00000402857 | |||
NHERF2 | ENST00000567504.5 | c.186+1393G>T | intron_variant | 3 | ENSP00000454361 |
Frequencies
GnomAD3 genomes AF: 0.0000198 AC: 3AN: 151254Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000823 AC: 6AN: 72930Hom.: 0 AF XY: 0.0000237 AC XY: 1AN XY: 42250
GnomAD4 exome AF: 0.0000111 AC: 14AN: 1262074Hom.: 0 Cov.: 31 AF XY: 0.0000145 AC XY: 9AN XY: 620752
GnomAD4 genome AF: 0.0000198 AC: 3AN: 151362Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 73982
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 18, 2023 | The c.54G>T (p.E18D) alteration is located in exon 1 (coding exon 1) of the SLC9A3R2 gene. This alteration results from a G to T substitution at nucleotide position 54, causing the glutamic acid (E) at amino acid position 18 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at